title: Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.
authors.forename: Eusebio S
authors.initials: ES
authors.lastname: Pires
authors.forename: Ryan S
authors.initials: RS
authors.lastname: D'Souza
authors.forename: Marisa A
authors.initials: MA
authors.lastname: Needham
authors.forename: Austin K
authors.initials: AK
authors.lastname: Herr
authors.forename: Amir A
authors.initials: AA
authors.lastname: Jazaeri
authors.forename: Hui
authors.initials: H
authors.lastname: Li
authors.forename: Mark H
authors.initials: MH
authors.lastname: Stoler
authors.forename: Kiley L
authors.initials: KL
authors.lastname: Anderson-Knapp
authors.forename: Theodore
authors.initials: T
authors.lastname: Thomas
authors.forename: Arabinda
authors.initials: A
authors.lastname: Mandal
authors.forename: Alain
authors.initials: A
authors.lastname: Gougeon
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Flickinger
authors.forename: David E
authors.initials: DE
authors.lastname: Bruns
authors.forename: Brian A
authors.initials: BA
authors.lastname: Pollok
authors.forename: John C
authors.initials: JC
authors.lastname: Herr